TY - JOUR
T1 - Tim-2 regulates T helper type 2 responses and autoimmunity
AU - Chakravarti, Sumone
AU - Sabatos, Catherine A.
AU - Xiao, Sheng
AU - Illes, Zsolt
AU - Cha, Eugene K.
AU - Sobel, Raymond A.
AU - Zheng, Xin X.
AU - Strom, Terry B.
AU - Kuchroo, Vijay K.
PY - 2005/8/1
Y1 - 2005/8/1
N2 - Identification of the T cell immunoglobulin mucin-domain containing (Tim) gene family introduced a new family of cell surface molecules that is involved in the regulation of immune responses. We previously demonstrated that Tim-3 is expressed on terminally differentiated T helper (Th)1 cells, and serves to regulate Th1 immune responses. Here, we describe the identification and function of Tim-2, a novel member of the Tim gene family. In contrast with Tim-3, we demonstrate that Tim-2 is expressed preferentially in differentiated Th2 cells. Blockade of the Tim-2/Tim-2 ligand interaction, by administration of soluble Tim-2 fusion protein (Tim-2 immunoglobulin [Ig]), results in T cell hyperproliferation and the production of Th2 cytokines. Administration of Tim-2 Ig during the induction phase reduces the severity of experimental autoimmune encephalomyelitis, a Th1-mediated autoimmune disease model of multiple sclerosis. We propose that Tim-2, an orthologue of human Tim-1, is critical for the regulation of Th2 responses during autoimmune inflammation. JEM
AB - Identification of the T cell immunoglobulin mucin-domain containing (Tim) gene family introduced a new family of cell surface molecules that is involved in the regulation of immune responses. We previously demonstrated that Tim-3 is expressed on terminally differentiated T helper (Th)1 cells, and serves to regulate Th1 immune responses. Here, we describe the identification and function of Tim-2, a novel member of the Tim gene family. In contrast with Tim-3, we demonstrate that Tim-2 is expressed preferentially in differentiated Th2 cells. Blockade of the Tim-2/Tim-2 ligand interaction, by administration of soluble Tim-2 fusion protein (Tim-2 immunoglobulin [Ig]), results in T cell hyperproliferation and the production of Th2 cytokines. Administration of Tim-2 Ig during the induction phase reduces the severity of experimental autoimmune encephalomyelitis, a Th1-mediated autoimmune disease model of multiple sclerosis. We propose that Tim-2, an orthologue of human Tim-1, is critical for the regulation of Th2 responses during autoimmune inflammation. JEM
UR - http://www.scopus.com/inward/record.url?scp=23744437449&partnerID=8YFLogxK
U2 - 10.1084/jem.20050308
DO - 10.1084/jem.20050308
M3 - Article
C2 - 16043519
AN - SCOPUS:23744437449
SN - 0022-1007
VL - 202
SP - 437
EP - 444
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 3
ER -